Inhibition of the RAGE Products Increases Survival in Experimental Models of Severe Sepsis and Systemic Infection

Critical Care - United Kingdom
doi 10.1186/cc6184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prophylactic Treatment With Simvastatin Modulates the Immune Response and Increases Animal Survival Following Lethal Sepsis Infection

Frontiers in Immunology
AllergyImmunology
2018English

Evaluation of the Source of Infection in Patients With Severe Sepsis

Critical Care
Critical CareIntensive Care Medicine
2007English

Cardiac RAGE in Sepsis: Call TOLL Free for Anti-Rage

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2008English

Systemic and Regional Hemodynamic Effects of Enalaprilat Infusion in Experimental Normotensive Sepsis

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2006English

Sepsis and Septic Encephalopathy: Characteristics and Experimental Models

Folia Neuropathologica
Forensic MedicinePathologyNeurology
2012English

Inhibition of Caspase-1 Activation in Gram-Negative Sepsis and Experimental Endotoxemia

Critical Care
Critical CareIntensive Care Medicine
2011English

Sepsis Bundle Adherence Is Associated With Improved Survival in Severe Sepsis or Septic Shock

Western Journal of Emergency Medicine
MedicineEmergency Medicine
1996English

Systemic Infection and Microglia Activation: A Prospective Postmortem Study in Sepsis Patients

Immunity and Ageing
AgingImmunology
2019English

Prophylactic Simvastatin Treatment Modulates the Immune Response and Increases Survival of Mice Following Induction of Lethal Sepsis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy